TRANSLATION IN PROKARYOTES

Protein Synthesis in Prokaryotes

Protein synthesis, also known as translation, is a fundamental biological process through which cells generate proteins based on the genetic information encoded in messenger RNA (mRNA). In prokaryotes, this process occurs in the cytoplasm and involves several key steps: initiation, elongation, and termination. The entire process is facilitated by various proteins and enzymes that play specific roles at each stage.

1. Transcription: Formation of mRNA

Before protein synthesis can occur, the DNA must first be transcribed into mRNA. This process is catalyzed by the enzyme RNA polymerase.

• RNA Polymerase: This enzyme binds to a specific region called the promoter on the DNA template strand and unwinds the DNA helix. It synthesizes a single strand of RNA by adding ribonucleotides complementary to the DNA template strand (A pairs with U, and C pairs with G).

Once transcription is complete, the mRNA molecule is released from RNA polymerase and undergoes minimal processing in prokaryotes compared to eukaryotes.

2. Initiation of Translation

The initiation phase of translation begins when the mRNA binds to the ribosome. In prokaryotes, this involves several key components:

• Ribosome: Prokaryotic ribosomes are 70S in size, composed of a 50S large subunit and a 30S small subunit. The small subunit binds to the mRNA at the Shine-Dalgarno sequence, which helps position it correctly for translation.
• Initiator tRNA: The initiator transfer RNA (tRNA) carries formylmethionine (fMet) in prokaryotes. This tRNA recognizes the start codon (AUG) on the mRNA.
• Initiation Factors (IFs): Several initiation factors (IF1, IF2, IF3) assist in assembling these components:
  • IF1 prevents premature binding of tRNAs.
  • IF2 facilitates the binding of fMet-tRNA to the start codon.
  • IF3 ensures that only the small ribosomal subunit binds initially.

Once all components are assembled correctly at the start codon, GTP is hydrolyzed by IF2 to provide energy for joining the large ribosomal subunit to form a complete ribosome ready for elongation.

3. Elongation Phase

During elongation, amino acids are sequentially added to form a polypeptide chain:

• Elongation Factors (EFs): Two main elongation factors are involved:
  • EF-Tu: This factor brings aminoacyl-tRNAs to the A site of the ribosome. It forms a complex with GTP; upon correct codon-anticodon pairing, GTP is hydrolyzed.
  • EF-G: This factor facilitates translocation of tRNAs from A site to P site after peptide bond formation.
• Peptidyl Transferase Activity: Catalyzed by rRNA within the large ribosomal subunit (50S), this activity forms peptide bonds between adjacent amino acids. The growing polypeptide chain is transferred from tRNA in P site to tRNA in A site.

This cycle continues until a stop codon on mRNA is reached.

4. Termination Phase

Termination occurs when a stop codon (UAA, UAG, or UGA) enters the A site:

• Release Factors (RFs): These proteins recognize stop codons and promote hydrolysis of the bond between tRNA and polypeptide chain:
  • RF1 or RF2: Depending on whether it’s UAA/UAG or UGA respectively.

Upon release of newly synthesized polypeptide from tRNA, ribosomal subunits dissociate from mRNA and each other with assistance from additional factors like EF-G.

5. Post-translational Modifications

While not part of protein synthesis per se, newly synthesized proteins may undergo post-translational modifications such as folding or cleavage before becoming fully functional.

In summary, protein synthesis in prokaryotes involves transcription followed by translation through initiation involving ribosomes and initiation factors; elongation facilitated by elongation factors; and termination mediated by release factors—all working together seamlessly to translate genetic information into functional proteins.

Effect of Antibiotics on Protein Synthesis in Prokaryotes

Antibiotics are critical tools in the fight against bacterial infections, and their effectiveness largely stems from their ability to inhibit protein synthesis in prokaryotic cells. Understanding how these antibiotics function at the ribosomal level provides insight into their mechanisms of action and the development of resistance.

1. Ribosomal Structure and Function in Prokaryotes

Prokaryotic ribosomes are composed of two subunits: a small 30S subunit and a large 50S subunit, which together form a 70S ribosome. This structure is essential for translating mRNA into proteins. The ribosome binds to mRNA and facilitates the interaction with transfer RNA (tRNA) during translation, which occurs in three main stages: initiation, elongation, and termination.

2. Mechanisms of Action of Antibiotics

Different classes of antibiotics target various stages of protein synthesis:

• Tetracyclines: These antibiotics bind reversibly to the 30S ribosomal subunit, blocking the binding of tRNA to the acceptor site on the mRNA-ribosome complex. This inhibition prevents the addition of amino acids to the growing polypeptide chain during elongation.
• Aminoglycosides: Such as gentamicin and streptomycin, these bind to the 16S rRNA within the 30S subunit, disrupting tRNA recognition by rRNA. This leads to misreading of mRNA and premature termination of protein synthesis.
• Oxazolidinones: These bind at the P site of the 50S subunit, inhibiting tRNA binding and preventing formation of the initiation complex. If a complex is already formed, they inhibit translocation during peptide bond formation.
• Amphenicols: They block peptidyl transfer during elongation on the 50S subunit by interfering with A site functions, thus halting protein synthesis.
• Lincosamides: Acting as structural analogs of tRNA portions, they interrupt peptide chain initiation in the 50S subunit and can cause dissociation of peptidyl-tRNA from ribosomes.
• Macrolides: These interact with 23S rRNA within the 50S subunit, blocking access to the peptide exit tunnel and causing premature release of incomplete polypeptides.
• Streptogramins: They act similarly to lincosamides and macrolides but have distinct binding sites that prevent substrate attachment or interfere with polypeptide elongation.

Each class has its unique mechanism but ultimately leads to inhibition or disruption of protein synthesis essential for bacterial growth and survival.

3. Development of Resistance

Bacterial resistance to these antibiotics often arises through various mechanisms such as:

• Decreased drug accumulation due to reduced influx or increased efflux.
• Structural modifications made by bacteria that alter antibiotic targets.
• Enzymatic modification or degradation of antibiotics.

These adaptations highlight an ongoing arms race between antibiotic development and bacterial resistance strategies.

In summary, antibiotics exert their effects on prokaryotic protein synthesis primarily by targeting specific components within ribosomes at different stages of translation. This targeted approach allows for effective treatment options against bacterial infections while also presenting challenges due to emerging resistance patterns.